...
首页> 外文期刊>European journal of epidemiology >Effectiveness of pertussis vaccination in New South Wales, Australia, 1996-1998.
【24h】

Effectiveness of pertussis vaccination in New South Wales, Australia, 1996-1998.

机译:1996-1998年,澳大利亚新南威尔士州的百日咳疫苗接种效果。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Pertussis notifications have increased over the past decade in Australia and other industrialised countries. This study estimates the effectiveness of pertussis vaccination in one Australian State (New South Wales, NSW) among children aged less than 14 years, during a period when an Australian whole-cell pertussis vaccine was in routine use. Cases notified with pertussis between 1996 and 1998 and pertussis vaccine coverage estimates from the Australian Childhood Immunisation Register were used. Vaccine effectiveness (VE) was calculated using the screening method, with adjustment for age group, year of disease onset and area of residence. VE was highest (91%) in the youngest age group (8-23 months) and lowest (78%) in the oldest age group (9-13 years). Pertussis vaccination is highly effective at preventing pertussis in NSW children, as measured by notified cases. Ongoing monitoring will be important to evaluate VE following Australia's change to an acellular vaccine based program.
机译:在过去的十年中,澳大利亚和其他工业化国家的百日咳通报有所增加。这项研究估算了在澳大利亚一个州(新南威尔士州,新南威尔士州)对常规使用澳大利亚全细胞百日咳疫苗的时期内未满14岁的儿童进行百日咳疫苗接种的有效性。使用1996年至1998年间被百日咳通报的病例和澳大利亚儿童免疫登记册中百日咳疫苗的覆盖率估计值。使用筛查方法计算疫苗效力(VE),并调整年龄组,疾病发作年份和居住地区。在年龄最小的组(8-23个月)中,VE最高(91%),在年龄最大的组(9-13岁)中最低(78%)。根据通报病例,百日咳疫苗对预防新南威尔士州儿童的百日咳非常有效。在澳大利亚改变基于无细胞疫苗的计划之后,持续的监测对于评估VE很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号